Sandu Pharmaceuticals Current Share Price | Sandu Pharmaceuticals Stock Screener
SANDUPHQ
Pharmaceuticals
Sandu Pharmaceuticals Current Stock Price Today
Live Share Price BSE
₹38.00
▲
0.49 (1.31%)
As of August 18, 2026, the live Sandu Pharmaceuticals share price (BSE: SANDUPHQ) is ₹38.00, up 1.31% from the previous close, with shares trading between ₹37.03 and ₹38.87 in today's trading session, and a 52-week range of ₹30.52–₹50.22.
Analyse SANDUPHQ share price charts and track historical price performance.
Use the Sandu Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sandu Pharmaceuticals Market Cap
₹35.70 Cr.
SANDUPHQ P/E Ratio (TTM)
22.96
Sandu Pharmaceuticals P/B Ratio
1.07
EPS (TTM)
₹1.60
Dividend Yield
2.16%
Debt to Equity
-
SANDUPHQ 52 Week High
₹50.22
Sandu Pharmaceuticals 52 Week Low
₹30.52
Operating Margin
3.00%
Profit Margin
-
SANDUPHQ Revenue (TTM)
₹14.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹56.00
Total Equity
₹42.00
Sandu Pharmaceuticals Current Share Price Chart
Track the current Sandu Pharmaceuticals share price and stock price with an interactive chart. Analyse SANDUPHQ price trends, trading volume, historical performance, and volatility across different timeframes — the complete Sandu Pharmaceuticals stock quote in one place.
Sandu Pharmaceuticals Company Profile - Fundamental Screener
Screen Sandu Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANDUPHQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE751D01014
Sandu Pharmaceuticals Balance Sheet Screener
Screen SANDUPHQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 56 | 52 | 54 |
| Current Assets | 26 | 22 | 26 |
| Fixed Assets | 18 | 18 | 17 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 42 | 41 | 39 |
| Share Capital | 10 | 10 | 10 |
| Reserves & Surplus | 32 | 31 | 30 |
Sandu Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Sandu Pharmaceuticals income statement and profit fundamentals.
Analyze SANDUPHQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sandu Pharmaceuticals share price evaluation.
| Item | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar | 2021-Sept | 2021-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 18 | 18 | 17 | 16 | 18 | 17 | 18 | 15 | 17 | 17 | 16 | 12 | 18 | 17 |
| Expenses | 14 | 17 | 17 | 17 | 15 | 17 | 16 | 17 | 15 | 16 | 16 | 16 | 11 | 17 | 17 |
| EBITDA | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Operating Profit % | 3.00% | 5.00% | 5.00% | 2.00% | 4.00% | 3.00% | 5.00% | 2.00% | 3.00% | 5.00% | 5.00% | 2.00% | 5.00% | 5.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS | 0.34 | 0.57 | 1.95 | 0.17 | 0.62 | 0.21 | 0.57 | 0.11 | 0.26 | 0.51 | 0.64 | 0.19 | 0.34 | 0.57 | 0.53 |
Sandu Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SANDUPHQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 1 | 1 | 0 |
| Investing Activities | 0 | -1 | 1 |
| Financing Activities | -1 | -1 | 1 |
| Net Cash Flow | 0 | -1 | 1 |
Sandu Pharmaceuticals Shareholding Pattern Screener
See Sandu Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Sandu Pharmaceuticals promoter holding and ownership changes for SANDUPHQ on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 37.79% | 37.79% | 37.79% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 37.02% | 36.98% | 37.01% | 36.77% | 36.57% | 35.90% | 35.34% | 34.97% |
| Other Holding | 25.19% | 25.23% | 25.19% | 20.32% | 20.53% | 21.20% | 21.75% | 22.12% |
| Shareholder Count | 10,268 | 10,298 | 10,284 | 10,284 | 10,226 | 10,287 | 10,333 | 10,246 |
Sandu Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Sandu Pharmaceuticals dividend history with payout and yield data.
View Sandu Pharmaceuticals dividend details including ex-dates and amounts for SANDUPHQ stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.80 | 2.62% |
| 2024-March | ₹0.80 | 1.63% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.75 | 1.43% |
| 2021-March | ₹0.50 | 0.71% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sandu Pharmaceuticals Stock Index Membership
See which indices include Sandu Pharmaceuticals stock.
Check SANDUPHQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sandu Pharmaceuticals Market Events Screener - Corporate Actions
Get Sandu Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Sandu Pharmaceuticals stock events that may affect SANDUPHQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-11 | 2026-09-11 | Annual General Meeting | NA | -7.14% |
| 2026-09-04 | 2026-09-04 | Dividend | ₹ 1.00 /share | -14.03% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 1.95% |
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | -1.85% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 2.05% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.51% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -3.84% |
| 2025-09-18 | 2025-09-18 | Dividend | ₹ 0.80 /share | -12.97% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.76% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 4.41% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -3.54% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.33% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 3.42% |
| 2024-09-19 | 2024-09-20 | Dividend | ₹ 0.80 /share | 4.55% |
| 2023-09-18 | 2023-09-19 | Dividend | ₹ 0.75 /share | 41.02% |
Sandu Pharmaceuticals Competitors Screener - Peer Comparison
Screen SANDUPHQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,072 | 38.12 | 61,674 | 12.69% | 11,565 | 47.09 |
| Divis Laboratories | 225,038 | 77.15 | 11,067 | 13.95% | 2,568 | 71.85 |
| Torrent Pharmaceuticals | 183,832 | 85.40 | 13,886 | 20.34% | 2,138 | 45.42 |
| Cipla | 117,138 | 34.91 | 29,045 | 2.24% | 3,870 | 50.74 |
| Zydus Life Science | 114,228 | 24.76 | 27,658 | 17.64% | 5,026 | 50.68 |
| Lupin | 102,191 | 18.41 | 29,039 | 26.75% | 5,356 | 30.04 |
| Dr Reddys Laboratories | 100,160 | 31.52 | 35,059 | 3.90% | 4,158 | 49.18 |
| Mankind Pharma | 100,160 | 48.34 | 14,636 | 14.85% | 1,938 | 43.34 |
| Laurus Labs | 96,489 | 89.94 | 6,868 | 22.01% | 890 | 61.64 |
| Aurobindo Pharma | 93,332 | 25.95 | 34,145 | 5.56% | 3,503 | 55.68 |
Sandu Pharmaceuticals Company Announcements - News Screener
Screen SANDUPHQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Approval Of Material Related Party Transactions Subject To Approval Of Shareholders | - |
| 2026-08-14 | Statement Of Deviation And Utilisation Of Funds For Q Ended 30.06.2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-14 | Intimation About The Date Of The Annual General Meeting | - |
| 2026-08-14 | Intimation About The Record Date | - |
| 2026-08-14 | Intimation About Book Closure For AGM | - |
| 2026-08-14 | Outcome And Results Of The Board Meeting Dated 11.08.2026 Was Submitted On Time But Inadvertently No Digital Signature Was Affixed On The Covering Letter Further There Is No Change In The Contents Of The Outcome | - |
| 2026-08-14 | Unaudited Financials For Q Ended 30.06.2026 | - |
| 2026-08-14 | Outcome Of The Board Meeting | - |
| 2026-08-14 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.08.2026 | - |
| 2026-08-03 | Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026. | - |
| 2026-07-11 | Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders | - |
| 2026-07-11 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-11 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 11.07.2026 | - |
| 2026-07-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-06 | Board Meeting Intimation for To Place On Record The Demise Of Shri Umesh B. Sandu(DIN:01132141) Managing Director Of The Company On 19Th June 2026 And To Record The Boards Appreciation For His Invaluable Contribution To The Company. | - |
| 2026-06-24 | Closure of Trading Window | - |